ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston – PR Newswire (press release)

Continue reading

2017-04-24 Michael Zand NEWS

ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston – PR Newswire (press release)

ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston
PR Newswire (press release)
SAN DIEGO, April 24, 2017 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced two presentations on April 27 at the Alliance for Regenerative Medicine’s 5th Annual Cell & Gene Therapy Investor Day in Boston.

and more »

Continue reading

2017-04-24 Michael Zand NEWS

Global Stem Cell Therapy Market Growth at CAGR of 36.52%, 2017-2021: Challenges, Trends & Drivers – Key Vendors … – Yahoo Finance

Global Stem Cell Therapy Market Growth at CAGR of 36.52%, 2017-2021: Challenges, Trends & Drivers – Key Vendors …Yahoo FinanceGlobal Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from indus… Continue reading

2017-04-24 Michael Zand NEWS

Protecting Baby: Cross-Channel Marketing To Sell A Stem Cell Service – MediaPost Communications

Protecting Baby: Cross-Channel Marketing To Sell A Stem Cell ServiceMediaPost CommunicationsCord Blood Registry faces an almost impossible task: The company stores stem cells extracted from the umbilical cords of newborn babies, and it has to sell this… Continue reading

2017-04-24 Michael Zand NEWS

More Tooth, More Tail in CRISPR Operations – Genetic Engineering & Biotechnology News (press release)

ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston
PR Newswire (press release)
SAN DIEGO, April 24, 2017 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced two presentations on April 27 at the Alliance for Regenerative Medicine’s 5th Annual Cell & Gene Therapy Investor Day in Boston.

and more »

Continue reading

2017-04-24 Michael Zand NEWS

More Tooth, More Tail in CRISPR Operations | GEN – Genetic Engineering & Biotechnology News (press release)


Genetic Engineering & Biotechnology News (press release)

More Tooth, More Tail in CRISPR Operations
Genetic Engineering & Biotechnology News (press release)
Although CRISPR/Cas9 is a fascinating technology, the most interesting thing about this cutting and pasting machine, this RNA-guided endonuclease, is what it can accomplish in the hands of gifted researchers. Eventually, CRISPR/Cas9 will become just …
Modified CRISPR Gene Editing Proves Highly AccurateAsian Scientist Magazine
Tang Prize winner delivers speech at EB 2017 in ChicagoFocus Taiwan News Channel (press release)

all 3 news articles »

Continue reading

2017-04-24 Michael Zand NEWS

CRISPR genome editing and immunotherapy – the early adopter – Medical Xpress


Genetic Engineering & Biotechnology News (press release)

More Tooth, More Tail in CRISPR Operations | GEN
Genetic Engineering & Biotechnology News (press release)
The tooth-to-tail ratio, or the balance of frontline troops to support echelons, can determine success or failure in any complicated operation. Originally a military …
Modified CRISPR Gene Editing Proves Highly Accurate | Asian …Asian Scientist Magazine

all 3 news articles »

Continue reading

2017-04-24 Michael Zand NEWS

Lack of demand forces uniQure to withdraw Glybera gene therapy in Europe – Pharmaceutical Business Review

Lack of demand forces uniQure to withdraw Glybera gene therapy in EuropePharmaceutical Business ReviewThe marketing authorization of the gene therapy was approved in 2012 for the treatment of patients with familial lipoprotein lipase deficiency (LPLD)… Continue reading

2017-04-24 Michael Zand NEWS
  • 1
  • …
  • 1,811
  • 1,812
  • 1,813
  • 1,814
  • 1,815
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medical Xpress

CRISPR genome editing and immunotherapy – the early adopter
Medical Xpress
It’s been a couple of years since the genome editing tool CRISPR first hit the headlines. And talk of its potential to cure all manner of diseases, create …

and more »